Editor-in-Chief eMediNexus – Dr KK Aggarwal
9th June 2019

Prefixing "Dr": Taking the Shine Away

Dr KK Aggarwal, Recipient of Padma Shri

Reproduced from: http://www.indialegallive.com/viewpoint/prefixing-dr-taking-the-shine-away-66572, published June 6, 2019

With the pharmacy council allowing its degree holders to use the "Dr" prefix, practitioners of modern medicine are irked and patients are left confused as to whom to go to in an emergency

As per Medical Council of India (MCI) ethics regulation 2.1, every doctor has an obligation towards the sick: "Though a physician is not bound to treat each and every person asking his services, he should not only be ever ready to respond to the calls of the sick and the injured, but should be mindful of the high character of his mission… A physician advising a patient to seek service of another physician is acceptable, however,...read more

Nipah Update: Duration of contact tracing

Dr KK Aggarwal

This page will be daily updated till the Nipah scare is over. Inputs invited in this white paper.

Duration of contact tracing is 21 days from the time of last contact with a case.

Active fever surveillance

Area: within 5 km radius from the periphery of the affected area (house/village of case/cases).

What has to be done

  • Enlist all houses (and persons): Daily visits to each house and enquire about any person developing any symptoms (like fever, cough, headache (and or other symptoms like altered sensorium, shortness of breath etc.)...read more
Video Of The Day : Know about Nipah Virus
Practice Updates

Nipah: Seven cases test negative, six more persons quarantined in Kochi

KOCHI: In a big relief, seven people admitted to a quarantine facility at Ernakulam government medical college hospital tested negative for Nipah virus on Thursday. Meanwhile, those admitted to isolation wards across the state rose to 13.

"Test reports from virology institutes in Pune and Alappuzha show the six persons negative for Nipah infection," health minister K K Shailaja said. ... read more

It might take 2 more years to contain Congo Ebola outbreak, WHO official says

In a "worst-case scenario," the current Ebola outbreak in the Democratic Republic of Congo may take up to two years to end, a World Health Organization official said Thursday.

The outbreak, which began on August 1, is "not under control," Dr. Mike Ryan, executive director of WHO Health Emergencies Programme, said during a press briefing. "We may end up dealing with this outbreak for a long time."... read more

FDA OKs Two Self-Administered Options for Mepolizumab

The US Food and Drug Administration (FDA) has approved two new methods for administering mepolizumab (Nucala, GlaxoSmithKline), an autoinjector and a prefilled safety syringe, which patients or caregivers can administer at home once every 4 weeks, the company announced.... read more

Genetic Testing May Help Identify Best Antidepressant

Pharmacogenomic testing may help clinicians choose the most effective antidepressant for their patients with major depressive disorder (MDD) with greater precision.

A study that examined the utility of such testing found that remission, response, and relief from depressive symptoms were greater among patients whose care was guided by such testing, compared to patients who received treatment as usual (TAU), which did not include genetic guidance.... read more

Midlife type 2 diabetes Tied to Cerebrovascular Disease

Type 2 diabetes was tied to a higher risk for cerebrovascular disease (CBD) later in life, according to a twin study.

In a cohort of over 33,000 individual twins, midlife type 2 diabetes was associated with 29% higher odds of cerebral infarction later in life compared with people without diabetes (OR 1.29, 95% CI 1.03-1.61), reported Rongrong Yang, PhD candidate, Tianjin Medical University in China, and colleagues.... read more

Medical Voice

ICMR moves to get Nipah antidote made in India with Australian help

NEW DELHI: India could soon have indigenously produced antidote to Nipah virus, a deadly disease that has hit Kerala second time in a row this year. The drug, however, is likely to be available for treatment only from next year in case of further outbreaks. Country's top health research agency, Indian Medical Research Council, has asked an Indian vaccine and pharmaceutical manufacturer, Serum Institute of India, to manufacture the experimental monoclonal antibody for compassionate use during any future outbreaks of Nipah in India or other neighbouring countries.... read more

IDEJ Update

Indian Diabetes Educator Journal (IDEJ), 1st of its kind in India aims to keep the members of diabetes care team abreast with concepts of DSME (Diabetes self-management education) and DSMS (Diabetes self-management support). IDEJ has set a new benchmark in educating the diabetes educators about evolving the concept of DSME- reaching to more than 25000 through Digital and Print Medium..... read more

eMedi Humor
Medicolegal Corner
eMedi Quiz
1.Succinyl CoA.
2. Propionyl CoA.
3. Acetyl CoA.
4. Malonyl CoA.
Lifestyle Updates
Inspirational Story 1: Cure for Sorrow
Inspirational Story 2: Monetary Reminder